Virginia Tech Scientists Lead Study on Tobacco Tax Impact

Nov.22.2022
Virginia Tech Scientists Lead Study on Tobacco Tax Impact
A $3.5 million, five-year study at Virginia Tech predicts tobacco tax effects on public health through a complex experimental market.

Scientists at the Fralin Biomedical Research Institute at Virginia Tech are leading a five-year, $3.5 million research project to predict the impact of tobacco taxes on health.


Taxation is one of the most effective ways to change behavior - it makes people think about their choices, including their choice to use tobacco," said Warren Bickel, professor at the Fralin Biomedical Research Institute and director of the Addictions Recovery Center at the institute.


Bickel's research project, funded by the National Cancer Institute of the National Institutes of Health in the United States, aims to predict the impact of tobacco tax proposals in a complex experimental market. This market is constantly evolving with the introduction of new products, such as low-nicotine cigarettes or electronic cigarettes.


According to Virginia Tech, this project could potentially provide research-based health policy guidance for new tobacco regulations and assess the impact of people's economic choices on health.


Taxation is one of the most effective ways to change behavior - it makes people consider their choices, including their choice to use tobacco.


Warren Bickel, Director of the Addictions Recovery Research Center at the Fralin Biomedical Research Institute.


Taxes can help people achieve better health by discouraging them from smoking. If you make the product more expensive, people will be less likely to use it. They can also encourage people to switch from the most harmful tobacco products to the least harmful ones," said Bickel, who is also the director of the research institute's Health Behavior Research Center.


He will consider health disparities related to tobacco by investigating socio-economic factors.


Smoking rates are higher among low-income populations, and disproportionate tax policies may have far-reaching direct and unforeseen effects," said Professor Becker of the Virginia Tech College of Science.


To gain definitive answers, Bickel's approach involves conducting experiments in the tobacco market, which is an invention of the Center for Addictions Recovery Research. Participants have an account and purchase tobacco products to reflect their typical buying behavior. Joint researchers involved in the project include Jeff Stein and Allison Tegge from the Fralin Biomedical Research Institute and Bickel.


The market places a combination of products, prices, and specific regulations under experimental control to enable researchers to estimate the impact of policies in a realistic environment.


In this context, researchers can predict the impact and health equity of proposed tax policies, including a proposal for equal taxation of all tobacco products, as well as other proposals based on the product's nicotine content, potential harm, or whether the tobacco product is already taxed. The FDA's revised risk designation.


We can implement policies in the experimental tobacco market and provide information on the effects of tobacco purchases on people," said Bickel. "For example, if legislators or regulators restrict access to one product over another, will it lead smokers to make less healthy or healthier choices? It is an ideal resource for studying the harm reduction potential of low-nicotine cigarettes and alternative nicotine products.


Statement:


This article has been compiled from third-party information and is intended for industry professionals for discussion and educational purposes.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity and accuracy of the article. The compilation of this article is only intended for industry communication and research purposes.


As the translation is limited by the compiler's ability, the translated article may not fully convey the original meaning. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Kentucky to issue provisional state licenses to tobacco, nicotine and vapor retailers who applied before Jan. 1, 2026
Kentucky to issue provisional state licenses to tobacco, nicotine and vapor retailers who applied before Jan. 1, 2026
Kentucky will issue provisional state licenses to tobacco, nicotine and vapor product retailers that applied for a license with the Department of Alcoholic Beverage Control (ABC) before Jan. 1, 2026.
Dec.31 by 2FIRSTS.ai
Product | Featuring a 1.47-inch TFT color display and up to 40W output, the Aspire Fluffi Pro launches in European channels.
Product | Featuring a 1.47-inch TFT color display and up to 40W output, the Aspire Fluffi Pro launches in European channels.
Aspire, a brand under Eigate Technology, has launched the open-system Fluffi Pro on its official website. It is now available via select online channels in Switzerland, Italy, and France at around €24.5, featuring upgrades over the standard Fluffi in power and battery capacity, screen configuration, high-wattage coil specs, and a redesigned side-fill/side-airflow structure.
Jan.13 by 2FIRSTS.ai
PMI reshuffles South Africa leadership, appoints first female general manager
PMI reshuffles South Africa leadership, appoints first female general manager
Philip Morris International (PMI) said it has appointed Buena Barnes as general manager of its South Africa business, marking the first time a woman has held the role in the country. Barnes previously oversaw finance for Sub-Saharan Africa and has worked at GlaxoSmithKline South Africa and British American Tobacco South Africa.
Jan.19 by 2FIRSTS.ai
China’s E-Cigarette Exports Fall Slightly to USD 10.6 Billion in 2025, U.S. Market Further Consolidates Lead
China’s E-Cigarette Exports Fall Slightly to USD 10.6 Billion in 2025, U.S. Market Further Consolidates Lead
China’s e-cigarette exports totaled approximately USD 10.60 billion in 2025, down 3.3% year-on-year from USD 10.96 billion in 2024, according to annual trade data released by the General Administration of Customs of China. Despite the mild decline, exports remained firmly above the USD 10 billion mark, with a clear rebound in the fourth quarter.
Jan.20 by 2FIRSTS.ai
Poland to ban “characterising flavours” in heated tobacco sticks from Jan. 18, 2026
Poland to ban “characterising flavours” in heated tobacco sticks from Jan. 18, 2026
Poland will implement an amended health protection law on January 18, 2026, restricting the availability of tobacco inserts used in heated tobacco devices. The new rules prohibit products with a “characterising flavour,” meaning a clearly noticeable taste or smell other than tobacco, derived from additives and detectable before or during use.
Jan.20 by 2FIRSTS.ai
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.
Dec.02 by 2FIRSTS.ai